CoChat

Combination of N ‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis

De Oliveira, Claudia Pinto Marques Souza, Stefano, José Tadeu, De Siqueira, Erika Rabelo Forte, Silva, Leonardo Soares, De Campos Mazo, Daniel Ferraz, Lima, Vicência Mara Rodrigues, Furuya, Carlos Kioshi, Mello, Evandro Sobroza, Souza, Fabrício G., Rabello, Fabíola, Santos, Telma Eugênio, Nogueira, Monize Aydar, Caldwell, Stephen H., Alves, Venâncio Avancini Ferreira, Carrilho, Flair José · 2008 · Hepatology Research
Cited by 109

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Aim: There is no proven medical therapy for the treatment of non‐alcoholic steatohepatitis (NASH). Oxidative stress and insulin resistance are the mechanisms that seem to be mostly involved in its pathogenesis. The aim of our study was to evaluate the efficacy of N ‐acetylcysteine (NAC) in combination with metformin (MTF) in improving the aminotransferases and histological parameters (steatosis, inflammation, hepatocellular ballooning, and fibrosis) after 12 months of treatment. Methods: Twenty consecutive patients (mean age 53 ± 2 years [36–68] and body mass index [BMI] 29 [25–35]) with biopsy‐proven NASH were enrolled in the study. NAC (1.2 g/day) and MTF (850–1000 mg/day) were given orally for 12 months. All patients underwent evaluation of serum aminotransferases, fasting lipid profile and serum glucose, anthropometric parameters, and nutritional status at 0 and 12 months. A low calorie diet was prescribed for all patients. Results: Serum alanine aminotransferase, high‐density lipoprotein, insulin, and glucose concentrations and thehomeostasis model assessment–insulin resistance (HOMA‐IR) index were reduced significantly at the end of study ( P < 0.05). The BMI declined, but without statistical significance. Aspartate aminotransferase, gamma‐glutamyl transferase, alkaline phosphatase, cholesterol, and triglycerides levels were not altered with the treatment. Liver steatosis and fibrosis decreased ( P < 0.05), but no improvement was noted in lobular inflammation or hepatocellular ballooning. The NASH activity score was significantly improved after treatment. Conclusion: Based on the biochemical and histological evidence in this pilot study, NAC in combination with MTF appears to ameliorate several aspects of NASH, including fibrosis. Further studies of this form of combination therapy are warranted to assess its potential efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1872-034x.2007.00215.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 109

Metadata

Authors
De Oliveira, C. P. M. S., Stefano, J. T., De Siqueira, E. R. F., Silva, L. S., De Campos Mazo, D. F., Lima, V. M. R., Furuya, C. K., Mello, E. S., Souza, F. G., Rabello, F., Santos, T. E., Nogueira, M. A., Caldwell, S. H., Alves, V. A. F., & Carrilho, F. J.
Venue
Hepatology Research
Publisher
Wiley
Published
2007-08-09
Volume
38
Issue
2
Pages
159-165
ISSN
  • 1386-6346 (ISSN-L)
  • 1872-034X
OpenAlex
W1994378142
Cited by
109
References
9
FWCI
3.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination of N ‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis. https://app.cochat.ai/papers/10.1111/j.1872-034x.2007.00215.x
The paper
De Oliveira, C. P. M. S., Stefano, J. T., De Siqueira, E. R. F., Silva, L. S., De Campos Mazo, D. F., Lima, V. M. R., Furuya, C. K., Mello, E. S., Souza, F. G., Rabello, F., Santos, T. E., Nogueira, M. A., Caldwell, S. H., Alves, V. A. F., & Carrilho, F. J. (2008). Combination of N ‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis. Hepatology Research. https://doi.org/10.1111/j.1872-034x.2007.00215.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.